EU_Haema_Contents_EU Haematology 05/03/2010 16:18 Page 5
Contents
Clinical Management of Relapsed/Refractory Acute Myeloid Leukaemia 43
Sameer A Parikh
1
and Stefan Faderl
2
1. Fellow; 2. Associate Professor of Medicine, Department of Leukemia, University of Texas MD Anderson Cancer Center
Deacetylase Inhibition in Haematological Malignancies – Advanced T-cell Lymphoma, Hodgkin’s
Lymphoma, Multiple Myeloma, Acute Myelogenous Leukaemia and Myelodysplastic Syndrome 47
Enrique M Ocio,
1
Patricia Maiso
2
and María-Victoria Mateos
1
1. Consultant Physician, Haematology Department, University Hospital of Salamanca;
2. Researcher, Dana-Farber Cancer Institute, Harvard University
Myeloproliferative Disorders
Philadelphia-negative Chronic Myeloproliferative Disorders in Children 51
Maria Luigia Randi
1
and Maria Caterina Putti
2
1. Professor of Haematology and Internal Medicine, Department of Medical and Surgical Science; 2. Physician,
Department of Paediatric Haematology-Oncology Clinic, Department of Paediatrics, Padua University Medical School
Diagnosis and Treatment of Erythrocytosis 55
Mary Frances McMullin
Professor of Clinical Haematology, Queens University, Belfast
Imatinib Blood Level Testing – Current Perspectives and Key Questions 59
François-Xavier Mahon,
1
Mathieu Molimard,
2
Kajetana Foryciarz,
3
Andrea Davies,
4
Carmen Fava,
5
David Friedecky,
6
Eberhard Schleyer,
7
Peter Schuld
8
and François Guilhot
9
1. Professor of Haematology and Medical Biology, University Hospital of Bordeaux; 2. Professor, Department of
Pharmacology, University of Bordeaux; 3. Staff Member, Haematology Department, Jagiellonian University;
4. Member, Chronic Myeloid Leukaemia Research Group, Department of Haematology, University of Liverpool;
5. Research Fellow, University of Turin; 6. Member, Laboratory for Inherited Metabolic Disorders, Department of Clinical
Biochemistry, University Hospital and Palacky University Olomouc; 7. Medical Director, Department II for Internal
Medicine, Carl von Basedow Hospital, Saalkreis; 8. Medical Director of Haematology, Novartis Oncology Region Europe
Business Unit; 9. Head, Department of Oncology Haematology and Cell Therapy, University Hospital Centre of Poitiers
Lymphoproliferative Disorders
The Spectrum of T-cell and Natural Killer–Large Granular Lymphocytic Proliferations 65
Estella Matutes
Honorary Consultant Haematologist, Royal Marsden Hospital, and Reader, Institute of Cancer Research, London
Progress in the Front-line Treatment of Multiple Myeloma 70
Stefan Knop,
1
Klaus Martin Kortüm
2
and Hermann Einsele
3
1. Consultant; 2. Staff Physician; 3. Full Professor of Internal Medicine, and Director, Department of Internal Medicine II,
Division of Haematology and Medical Oncology, University Hospital Würzburg
The Treatment of Diffuse Large B-cell Lymphoma with Poor Prognosis in the
Rituximab Era – State of the Art and Future Perspectives 75
Umberto Vitolo,
1
Annalisa Chiappella,
2
Chiara Frairia
3
and Barbara Botto
4
1. Director; 2. Clinical Research Fellow; 3. Haematology Fellow; 4. Permanent Staff Member,
Department of Haematology 2, San Giovanni Battista Hospital and University of Turin
Recurrent Genomic Aberrations in Chronic Lymphocytic Leukaemia –
Implications for Disease Pathogenesis and Prognosis 80
Mahmoud Mansouri
1
and Richard Rosenquist
2
1. Scientist; 2. Professor of Molecular Genetics, Department of Genetics and Pathology, Uppsala University
Balancing the Efficacy and Tolerability of First-line Treatment in Elderly Myeloma Patients 85
Valeria Magarotto
1
and Antonio Palumbo
2
1.Resident, Department of Haematology; 2. Chief, Myeloma Unit, Department of Oncology, Section of Haematology, University of Turin
The Cancer Stem Cell Concept in Multiple Myeloma – From Phenomenology to Characterisation 94
Kirsten Fogd,
1
Steen Møller Hansen,
2
Louise Hvilshøj Madsen,
3
Malene Krag Kjeldsen
4
and Hans E Johnsen
5
1. Post-doctoral Researcher; 2. Research Assistant; 3. Research Laboratory Technician; 4. PhD Student; 5. Professor of Clinical
Haematology, Department of Haematology, Aalborg Hospital, Aarhus University Hospital
EUROPEAN HAEMATOLOGY 5
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100